Elastro develops an Intelligent Neural System (INS) that combines a soft, flexible neural ribbon densely packed with electrodes and proprietary machine‑intelligence to enable bi‑directional, real‑time communication with thousands of neurons. The AI‑driven implant continuously monitors neural activity and delivers precise, adaptive electrical stimulation for drug‑free treatment of refractory neurological disorders such as epilepsy, Parkinson’s disease, OCD, addiction, depression, and chronic pain. By conforming to brain movement and reaching deep brain regions, the platform offers higher spatial resolution, broader coverage, and personalized therapy for neurosurgeons and specialty clinics.
Funding
Funding not disclosed
Founders
Product
Problem
Current treatments for neurological disorders such as epilepsy, Parkinson’s disease, OCD, addiction, depression, and chronic pain rely heavily on pharmaceuticals or conventional deep brain stimulation devices that are rigid, low‑resolution, and limited in coverage, leading to suboptimal efficacy, side effects, and invasive procedures.
Solution
Elastro develops an Intelligent Neural System (INS) that combines a soft, flexible neural ribbon densely packed with electrodes and proprietary machine‑intelligence algorithms. The implant conforms to brain movement, reaches deep brain regions, and establishes bi‑directional communication with thousands of neurons. Integrated AI continuously monitors neural activity and delivers precise, adaptive electrical stimulation in real time, enabling drug‑free therapy and personalized diagnosis. The platform expands beyond traditional deep brain stimulation by offering higher spatial resolution, broader brain coverage, and self‑learning capabilities that adjust treatment parameters automatically. This approach aims to improve therapeutic outcomes, reduce hospitalizations, and open new possibilities for functional restoration.
Target Audience
Primary customers are neurosurgeons, neurologists, and specialty clinics treating patients with refractory epilepsy, Parkinson’s disease, OCD, and other chronic neurological disorders.
Features
- Soft, flexible neural ribbon with high‑density electrode array for extensive, high‑resolution brain coverage
- Bi‑directional communication enabling real‑time sensing and adaptive stimulation of thousands of neurons
- Proprietary machine‑intelligence that continuously learns from neural signals to personalize therapy
- Conformable design that moves with brain tissue, minimizing tissue damage and improving safety
- Capability to target deep brain structures inaccessible to surface‑level brain‑computer interfaces
- Integrated platform for real‑time diagnosis and treatment of multiple neurological conditions